Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#131 / 200 Total
RAIL - FreightCar America Inc - Stock Price Chart
TickerRAIL [NASD]
CompanyFreightCar America Inc
CountryUSA
IndustryRailroads
Market Cap69.41MEPS (ttm)-1.48
P/E-EPS this Y146.15%
Forward P/E9.89EPS next Y108.33%
PEG-EPS past 5Y18.51%
P/S0.16EPS next 5Y3.00%
P/B-EPS Q/Q-184.14%
Dividend-Sales Q/Q98.84%
Insider Own32.82%Inst Own30.67%
Insider Trans0.55%Inst Trans-0.94%
Short Float1.08%EarningsMay 08/a
Analyst Recom3.00Target Price4.50
Avg Volume47.79K52W Range2.25 - 4.26
FreightCar America, Inc. engages in the manufacture of railcars and railcar components. It operates through the Manufacturing and Corporate and Other segments. The Manufacturing segment includes new railcar manufacturing, used railcar sales, railcar leasing and major railcar rebuilds. The Corporate and Other segment focuses on the sales of parts. The company was founded in 1901 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gil Benavides Jesus SalvadorDirectorApr 09 '24Option Exercise2.43317,022768,811345,794Apr 11 03:16 PM
Gil Benavides Alejandro10% OwnerDec 14 '23Buy2.4421,40052,216180,000Dec 20 04:17 PM
ACIU - AC Immune SA - Stock Price Chart
TickerACIU [NASD]
CompanyAC Immune SA
CountrySwitzerland
IndustryBiotechnology
Market Cap315.46MEPS (ttm)-0.69
P/E-EPS this Y28.21%
Forward P/E48.54EPS next Y112.87%
PEG-EPS past 5Y3.28%
P/S18.91EPS next 5Y-
P/B1.86EPS Q/Q9.19%
Dividend-Sales Q/Q-
Insider Own41.87%Inst Own29.75%
Insider Trans0.00%Inst Trans0.98%
Short Float0.88%EarningsMay 13/b
Analyst Recom1.00Target Price10.42
Avg Volume779.77K52W Range1.90 - 5.14
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
RKDA - Arcadia Biosciences Inc - Stock Price Chart
TickerRKDA [NASD]
CompanyArcadia Biosciences Inc
CountryUSA
IndustryPackaged Foods
Market Cap1.89MEPS (ttm)-5.29
P/E-EPS this Y66.53%
Forward P/E-EPS next Y16.79%
PEG-EPS past 5Y39.82%
P/S0.35EPS next 5Y14.96%
P/B0.39EPS Q/Q83.61%
Dividend-Sales Q/Q-16.83%
Insider Own2.60%Inst Own37.92%
Insider Trans4.54%Inst Trans-
Short Float1.78%EarningsMay 09/a
Analyst Recom1.00Target Price11.00
Avg Volume28.60K52W Range1.85 - 5.60
Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schaefer Thomas J.Chief Financial OfficerFeb 01 '24Buy2.067001,4421,419Feb 05 04:29 PM
Schaefer Thomas J.Chief Financial OfficerAug 04 '23Buy3.676492,382719Aug 07 07:55 PM
Jacot Stanley JrChief Executive OfficerMay 30 '23Buy4.315,00021,5505,000May 30 06:24 PM
TLRY - Tilray Brands Inc - Stock Price Chart
TickerTLRY [NASD]
CompanyTilray Brands Inc
CountryCanada
IndustryDrug Manufacturers - Specialty & Generic
Market Cap1.60BEPS (ttm)-0.50
P/E-EPS this Y87.41%
Forward P/E-EPS next Y70.42%
PEG-EPS past 5Y-23.57%
P/S2.15EPS next 5Y37.00%
P/B0.46EPS Q/Q93.54%
Dividend-Sales Q/Q29.36%
Insider Own1.28%Inst Own10.01%
Insider Trans0.94%Inst Trans6.27%
Short Float14.51%EarningsApr 09/b
Analyst Recom2.50Target Price2.37
Avg Volume35.12M52W Range1.50 - 3.40
Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FALTISCHEK DENISE MChief Strategy OfficerJan 17 '24Buy2.0510,00020,500293,269Jan 18 08:32 AM
Gendel MitchellGlobal General CounselJan 16 '24Buy1.987,20014,256195,796Jan 16 01:07 PM
SIMON IRWIN DPresident and CEOJan 12 '24Buy1.8853,700100,9562,033,058Jan 12 03:36 PM
Merton Carl AChief Financial OfficerJan 12 '24Buy1.8720,00037,40020,000Jan 12 03:36 PM
Gendel MitchellGlobal General CounselJan 12 '24Buy1.875,40010,098188,596Jan 12 03:39 PM
ZONE - CleanCore Solutions Inc. - Stock Price Chart
TickerZONE [AMEX]
CompanyCleanCore Solutions Inc.
CountryUSA
IndustryPollution & Treatment Controls
Market Cap25.96MEPS (ttm)-0.20
P/E-EPS this Y-886.50%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S15.27EPS next 5Y-
P/B-EPS Q/Q91.90%
Dividend-Sales Q/Q-62.50%
Insider Own74.42%Inst Own-
Insider Trans24.34%Inst Trans-
Short Float1.13%Earnings-
Analyst Recom-Target Price-
Avg Volume117.16K52W Range2.93 - 4.24
CleanCore Solutions, Inc. engages in developing, manufacturing, and selling cleaning products that produces pure aqueous ozone for professional, industrial, and home use. The company's product includes fill station, power caddy, and power minicaddy, ice treatment machine, commercial laundry, and residential laundry. It offers products and solutions that are marketed for janitorial and sanitation, ice machine cleaning, laundry, and industrial industries. CleanCore Solutions, Inc. was formerly known as CC Acquisition Corp. and changed its name to CleanCore Solutions, Inc. in November 2022. The company was incorporated in 2022 and is based in Omaha, Nebraska.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Adams Clayton10% OwnerMay 16 '24Buy3.575,00017,850475,000May 17 05:02 PM
Cox BrentDirectorMay 10 '24Buy0.26880,000224,928880,000May 14 06:06 AM
Ansari Mohammad Jawad10% OwnerApr 30 '24Buy4.01125,000501,2501,461,207May 08 04:09 PM
Adams Clayton10% OwnerApr 30 '24Buy3.105,00015,500470,000May 02 05:53 PM
Adams Clayton10% OwnerApr 26 '24Buy4.01145,000581,450465,000Apr 26 04:05 PM
CDTX - Cidara Therapeutics Inc - Stock Price Chart
TickerCDTX [NASD]
CompanyCidara Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap51.12MEPS (ttm)-8.07
P/E-EPS this Y-136.67%
Forward P/E22.12EPS next Y104.12%
PEG-EPS past 5Y37.54%
P/S1.10EPS next 5Y-
P/B-EPS Q/Q-458.81%
Dividend-Sales Q/Q-67.44%
Insider Own9.12%Inst Own28.31%
Insider Trans-16.32%Inst Trans-
Short Float2.02%EarningsMay 15/a
Analyst Recom1.00Target Price72.50
Avg Volume63.56K52W Range10.00 - 29.60
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tari LeslieCHIEF SCIENTIFIC OFFICERMar 11 '24Sale0.6721,02914,085258,681Mar 12 09:48 PM
Sandison TaylorChief Medical OfficerMar 11 '24Sale0.6720,66213,839347,095Mar 12 09:47 PM
Ward ShaneCOO & CLOMar 11 '24Sale0.6720,47313,713198,770Mar 12 09:46 PM
Shah PreetamCFO & CBOMar 11 '24Sale0.6718,93112,680227,210Mar 12 09:45 PM
Sandison TaylorChief Medical OfficerSep 11 '23Sale0.9518,79317,810363,757Sep 13 04:22 PM
PRLD - Prelude Therapeutics Inc - Stock Price Chart
TickerPRLD [NASD, RUT]
CompanyPrelude Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap219.72MEPS (ttm)-2.01
P/E-EPS this Y14.98%
Forward P/E-EPS next Y17.32%
PEG-EPS past 5Y-43.14%
P/S-EPS next 5Y30.10%
P/B1.04EPS Q/Q28.52%
Dividend-Sales Q/Q-
Insider Own52.76%Inst Own30.25%
Insider Trans0.00%Inst Trans-2.03%
Short Float2.43%EarningsMay 07/b
Analyst Recom3.00Target Price4.75
Avg Volume51.38K52W Range1.66 - 6.61
Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vaddi KrishnaCEOMay 25 '23Buy5.319004,7791,067,275May 26 04:20 PM
Lim Bryant DavidChief Legal Officer, Corp Sec.May 24 '23Buy5.392,40012,9362,400May 25 04:07 PM
Vaddi KrishnaCEOMay 24 '23Buy5.011,0005,0111,066,375May 26 04:20 PM
Vaddi KrishnaCEOMay 23 '23Buy5.6311,85666,7491,065,375May 25 04:03 PM
Chardonnet LaurentChief Financial OfficerMay 23 '23Buy5.505,00027,50042,165May 25 04:05 PM
TCON - TRACON Pharmaceuticals Inc - Stock Price Chart
TickerTCON [NASD]
CompanyTRACON Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap3.83MEPS (ttm)0.65
P/E2.21EPS this Y-89.70%
Forward P/E-EPS next Y31.39%
PEG-EPS past 5Y61.51%
P/S0.32EPS next 5Y-
P/B-EPS Q/Q81.52%
Dividend-Sales Q/Q-
Insider Own7.89%Inst Own10.94%
Insider Trans0.00%Inst Trans-0.85%
Short Float6.20%EarningsMay 14/a
Analyst Recom1.67Target Price37.50
Avg Volume272.08K52W Range1.51 - 14.75
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. The company was founded in October 2004 and is headquartered in San Diego, CA.
OKLO - Oklo Inc. - Stock Price Chart
TickerOKLO [NYSE]
CompanyOklo Inc.
CountryUSA
IndustryShell Companies
Market Cap388.33MEPS (ttm)0.19
P/E48.18EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.31EPS Q/Q-26.50%
Dividend-Sales Q/Q-
Insider Own32.37%Inst Own55.29%
Insider Trans0.00%Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume1.81M52W Range7.77 - 18.80
Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.
APGE - Apogee Therapeutics Inc. - Stock Price Chart
TickerAPGE [NASD, RUT]
CompanyApogee Therapeutics Inc.
CountryUSA
IndustryBiotechnology
Market Cap1.87BEPS (ttm)-
P/E-EPS this Y22.62%
Forward P/E-EPS next Y-23.74%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B3.67EPS Q/Q-158.66%
Dividend-Sales Q/Q-
Insider Own-Inst Own118.49%
Insider Trans-Inst Trans-
Short Float-EarningsMay 13/b
Analyst Recom1.00Target Price84.83
Avg Volume717.21K52W Range14.19 - 72.29
Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fairmount Funds Management LLCDirectorJul 13 '23Buy17.002,941,17649,999,9921,992,734Jul 17 08:00 PM
Shah Nimish PDirectorJul 13 '23Buy17.001,750,00029,750,0001,750,000Jul 17 08:00 PM
191011121314151617181920